Cargando…
A Zigzag but Upward Way to Develop an HIV-1 Vaccine
After decades of its epidemic, the human immunodeficiency virus type 1 (HIV-1) is still rampant worldwide. An effective vaccine is considered to be the ultimate strategy to control and prevent the spread of HIV-1. To date, hundreds of clinical trials for HIV-1 vaccines have been tested. However, the...
Autores principales: | Wen, Ziyu, Sun, Caijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564621/ https://www.ncbi.nlm.nih.gov/pubmed/32911701 http://dx.doi.org/10.3390/vaccines8030511 |
Ejemplares similares
-
Strategies to Develop a Mucosa-Targeting Vaccine against Emerging Infectious Diseases
por: Feng, Fengling, et al.
Publicado: (2022) -
First clinical study of germline-targeting strategy: One step closer to a successful bnAb-based HIV vaccine
por: Sun, Caijun, et al.
Publicado: (2023) -
Chromatin zigzags
por: Tuma, Rabiya S.
Publicado: (2006) -
Chico Zigzag
por: Grossman, David, 1954-
Publicado: (1998) -
B cell engineering in vivo: Accelerating induction of broadly neutralizing antibodies against HIV-1 infection
por: Sun, Caijun, et al.
Publicado: (2023)